美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,248.89

+19.721.60%

漲家數：6

跌家數：1

平家數：- -

市盈率：- -

高：1,251.72

開：1,229.96

低：1,229.96

收：1,229.17

資料載入中...

美國衞生部長對 COVID 疫苗療效表示擔憂後，Novavax 股價暴跌

Altimmune, Inc.盤中異動快速下跌5.32%

碩迪生物盤中異動股價大跌5.04%報14.50美元

安進盤中異動早盤股價大跌3.00%

輝瑞盤中異動早盤股價大跌3.00%報21.82美元

諾和諾德盤中異動快速跳水3.56%

輝瑞4月9日成交額為20.87億美元

諾和諾德4月9日成交額為8.25億美元

安進4月9日成交額為17.28億美元

Altimmune, Inc.盤中異動快速上漲5.45%

媒體-前輝瑞科學家 Mikael Dolsten 加入 Blackstone 生命科學部門擔任高級顧問 - 彭博新聞社

10.9億美元！諾和諾德加碼巴西產能

生物药大时代

諾和諾德盤中異動早盤股價大跌3.00%報59.76美元

美股三大指數開盤漲跌不一

Viking Therapeutics, Inc.盤中異動早盤快速下挫5.11%報18.96美元

碩迪生物盤中異動股價大跌5.27%

安進盤中異動急速下挫3.20%

輝瑞盤中異動早盤大幅跳水4.01%

禮來盤中異動股價大跌3.17%

環球財經巴西宣佈史上最大醫藥領域私人投資

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1248.89,"timestamp":1745351999999,"preClose":1229.1708,"halted":0,"volume":59332223,"delay":0,"changeRate":0.016043,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":19.719238,"latestTime":"04-22 16:00:00 EDT","open":1229.9553,"high":1251.7179,"low":1229.9553,"amount":4734339237.43625,"amplitude":0.017705,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.990998,"peRate":34.826857,"turnoverRate":0.005617,"increases":6,"decrements":1,"flats":0,"marketCap":1332454704192,"floatMarketCap":1254704086112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1251.7179,"amplitude":0.017705,"preClose":1229.1708,"low":1229.9553,"pbRate":"9.990998","latestPrice":1248.89,"volume":59332223,"delay":0,"open":1229.9553,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1208.2393,"twentyDayClose":1377.3098,"sixtyDayClose":1328.9048,"secType":"PLATE","market":"US","turnoverRate":0.005617,"peRate":34.826857,"marketCap":1332454704192,"floatMarketCap":1254704086112,"timestamp":1745351999999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2526548038","title":"美國衞生部長對 COVID 疫苗療效表示擔憂後，Novavax 股價暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2526548038","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526548038?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 02:56","pubTimestamp":1744311416,"startTime":"0","endTime":"0","summary":"路透社4月10日 - 疫苗生产商NovavaxNVAX.O的股价周四暴跌22%以上，因为卫生与公众服务部部长小罗伯特-肯尼迪在接受哥伦比亚广播公司采访时对该公司的COVID-19疫苗表示担忧。自 2022 年以来，该疫苗一直在紧急使用授权下销售。当被问及延迟是否是由于 FDA 的 \"人事变动 \"时，肯尼迪将其归因于疫苗的成分。他说，Novavax 的单一抗原方法在呼吸道疾病方面 \"从未奏效\"。这家总部位于马里兰州的公司生产的基于蛋白质的COVID-19疫苗是竞争对手辉瑞PFE.N和ModernaMRNA.O基于mRNA技术的替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nL3T3QO1IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","BK4550","LU0985481810.HKD","LU1883839398.USD","BK4501","IE000M9KFDE8.USD","NVAX","BK4548","LU0456855351.SGD","SG9999011175.SGD","BK4551","LU1066053197.SGD","BK4139","LU1066051498.USD","LU0306806265.USD","SG9999002232.USD","LU1057294990.SGD","BK4534","BK4592","LU0225771236.USD","SGXZ57979304.SGD","MRNA","SG9999003800.SGD","IE00BLSP4239.USD","BK4599","BK4581","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","LU1894683348.USD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","SG9999013999.USD","SG9999002224.SGD","BK4568","IE0002270589.USD","LU0868494617.USD","LU0289739699.SGD","LU1894683264.USD"],"gpt_icon":1},{"id":"2526515824","title":"Altimmune, Inc.盤中異動 快速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526515824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526515824?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 00:02","pubTimestamp":1744300935,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日00时02分，Altimmune, Inc.股票出现波动，股价急速下跌5.32%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为3.82%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Pasithea Therapeutics Corp.、Pmgc Holdings Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3467.46%、2249.97%、337.81%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc.，振幅分别为81.65%、71.43%、70.97%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411000215a4551954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411000215a4551954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2526865597","title":"碩迪生物盤中異動 股價大跌5.04%報14.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526865597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526865597?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 23:13","pubTimestamp":1744298038,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日23时13分，硕迪生物股票出现波动，股价大幅跳水5.04%。截至发稿，该股报14.50美元/股，成交量30.6053万股，换手率0.53%，振幅2.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-6.23倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为2.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231359aa2c6a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231359aa2c6a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","GPCR","BK4139","BK4599","BK4007"],"gpt_icon":0},{"id":"2526040567","title":"安進盤中異動 早盤股價大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526040567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526040567?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:39","pubTimestamp":1744292368,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时39分，安进股票出现波动，股价急速下跌3.00%。截至发稿，该股报282.36美元/股，成交量15.8267万股，换手率0.03%，振幅1.94%。最近的财报数据显示，该股实现营业收入332.32亿美元，净利润40.90亿美元，每股收益7.62美元，毛利213.33亿美元，市盈率37.44倍。安进股票所在的制药行业中，整体跌幅为2.38%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021392894d1e441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021392894d1e441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU2242652126.USD","IE00B2B36J28.USD","AMGN","LU0289739699.SGD","BK4588","LU1023059063.AUD","LU1983299246.USD","LU0320765992.SGD","LU1061106388.HKD","IE00BFTCPJ56.SGD","BK4585","IE0002141913.USD","BK4599","LU2468319806.SGD","LU0889565916.HKD","LU1571399168.USD","BK4533","LU0122379950.USD","IE0009355771.USD","LU2089984988.USD","LU2242646821.SGD","LU1057294990.SGD","BK4139","LU0058720904.USD","LU2112291526.USD","BK4534","LU0868494617.USD","LU0109394709.USD","BK4581"],"gpt_icon":0},{"id":"2526567401","title":"輝瑞盤中異動 早盤股價大跌3.00%報21.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526567401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526567401?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:37","pubTimestamp":1744292234,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时37分，辉瑞股票出现异动，股价快速下跌3.00%。截至发稿，该股报21.82美元/股，成交量380.117万股，换手率0.07%，振幅1.65%。辉瑞股票所在的制药行业中，整体跌幅为2.16%。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。消息层面，截至21时37分，《高盛：下调Pfizer评级，由买入调整至中性评级, 目标价由32.00美元调整至25.00美元。》资讯为影响辉瑞的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213714a4550320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213714a4550320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","SG9999003800.SGD","LU1066053197.SGD","PFE","LU1023059063.AUD","SG9999002232.USD","BK4568","IE00B19Z3B42.SGD","LU0234572021.USD","BK4581","LU0321505868.SGD","LU1066051498.USD","BK4585","LU0868494617.USD","LU1883839398.USD","BK4588","IE00BLSP4239.USD","BK4599","LU0122379950.USD","LU0225284248.USD","SG9999001176.USD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4534","SGXZ57979304.SGD","SG9999002224.SGD","LU0306807586.USD","BK4533","LU0289739699.SGD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","IE0002270589.USD","LU1894683264.USD","BK4007","LU1894683348.USD","LU0058720904.USD","BK4550","SG9999013999.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2526019593","title":"諾和諾德盤中異動 快速跳水3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526019593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526019593?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 21:33","pubTimestamp":1744291983,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时33分，诺和诺德股票出现波动，股价快速下挫3.56%。诺和诺德股票所在的制药行业中，整体跌幅为1.69%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。消息层面，截至21时33分，《两家国产GLP-1要在美国和诺和诺德打“三国杀”》资讯为影响诺和诺德的重要信息。健友股份在公告中表示，新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213303a6b6a911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213303a6b6a911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","LU1093756168.USD","BK4007","BK4588","BK4599","NVO","BK4532","IE00BKVL7J92.USD","LU0154236417.USD"],"gpt_icon":1},{"id":"2526375294","title":"輝瑞4月9日成交額為20.87億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526375294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526375294?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 10:14","pubTimestamp":1744251255,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，辉瑞成交额为20.87亿美元，成交额较昨日增加30.20%，当日成交量为9595.44万股。辉瑞于2025年4月9日涨2.98%，报22.49美元，该股过去5个交易日跌8.95%，年初至今跌13.82%，过去60日跌14.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-09|20.87亿|30.20%|9595.44万|#|2025-04-08|16.03亿|-17.07%|7240.60万|#|2025-04-07|19.33亿|3.74%|8610.61万|#|2025-04-04|18.63亿|41.94%|8000.26万|#|2025-04-03|13.12亿|27.07%|5350.18万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410101416a4546400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410101416a4546400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2526376587","title":"諾和諾德4月9日成交額為8.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526376587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526376587?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 10:08","pubTimestamp":1744250911,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，诺和诺德成交额为8.25亿美元，成交额较昨日增加62.43%，当日成交量为1324.33万股。诺和诺德于2025年4月9日涨5.67%，报65.09美元，该股过去5个交易日跌4.62%，年初至今跌23.43%，过去60日跌22.16%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410100832a45462ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410100832a45462ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4007","BK4588","IE00BKVL7J92.USD","BK4599","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","BK4532","LU0154236417.USD"],"gpt_icon":1},{"id":"2526240483","title":"安進4月9日成交額為17.28億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526240483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526240483?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 09:15","pubTimestamp":1744247756,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，安进成交额为17.28亿美元，成交额较昨日增加48.17%，当日成交量为605.57万股。安进于2025年4月9日涨3.86%，报291.09美元，该股过去5个交易日跌4.78%，年初至今涨12.58%，过去60日涨8.6%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091608a6b5fc9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091608a6b5fc9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1061106388.HKD","SG9999001440.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","AMGN","BK4585","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0122379950.USD","BK4581","BK4534","LU2242646821.SGD","LU2242652126.USD","LU2112291526.USD","BK4566","IE0002141913.USD","BK4599","LU0109394709.USD","LU0320765992.SGD","LU1023059063.AUD","IE0009355771.USD","BK4139","LU1983299246.USD","IE00BJT1NW94.SGD","BK4533","LU2089984988.USD","LU2468319806.SGD","LU0289739699.SGD","LU0868494617.USD","LU0889565916.HKD","BK4588","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2526315851","title":"Altimmune, Inc.盤中異動 快速上漲5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526315851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526315851?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 01:21","pubTimestamp":1744219283,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日01时21分，Altimmune, Inc.股票出现异动，股价快速上涨5.45%。截至发稿，该股报3.87美元/股，成交量148.426万股，换手率1.93%，振幅7.36%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Phio Pharmaceuticals Corp.、Hepion Pharmaceuticals, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Hepion Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Aditxt, Inc.较为活跃，换手率分别为7404.68%、2928.63%、225.38%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Moolec Science Sa C/Wts 、Hepion Pharmaceuticals, Inc.，振幅分别为138.61%、108.26%、80.93%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012123a453f8b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410012123a453f8b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2526397804","title":"媒體-前輝瑞科學家 Mikael Dolsten 加入 Blackstone 生命科學部門擔任高級顧問 - 彭博新聞社","url":"https://stock-news.laohu8.com/highlight/detail?id=2526397804","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526397804?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 00:34","pubTimestamp":1744216457,"startTime":"0","endTime":"0","summary":"媒体-前辉瑞科学家 Mikael Dolsten 加入 Blackstone 生命科学部门担任高级顾问 - 彭博新闻社4月9日 -  -- 来源链接： https://tinyurl.com/yr6ebx5v  -- 注：路透社未核实此报道，不保证其准确性(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nL3S3QN1T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","IE00B64PRP62.GBP","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","IE00B3QW5Z07.USD","BK4599","LU0122379950.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","BX","LU0306807586.USD","BK4585","IE00BLSP4239.USD","IE00BN8TJ469.HKD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","IE00BGHQF748.EUR","LU0225771236.USD","PFE","SG9999001176.USD","LU0456855351.SGD","SG9999001176.SGD","BK4550","SGXZ57979304.SGD","LU1894683348.USD","IE0004445239.USD","BK4135"],"gpt_icon":0},{"id":"2526343187","title":"10.9億美元！諾和諾德加碼巴西產能","url":"https://stock-news.laohu8.com/highlight/detail?id=2526343187","media":"生物药大时代","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526343187?lang=zh_tw&edition=fundamental","pubTime":"2025-04-10 00:28","pubTimestamp":1744216111,"startTime":"0","endTime":"0","summary":"近日，诺和诺德公司宣布，计划在巴西投资高达10.9亿美元，用于在蒙特莫尔市现有工厂的扩建。诺和诺德此次在巴西的投资计划堪称历史上规模最大的制药投资之一。如此大规模的扩建，标志着诺和诺德对于巴西市场的重视，以及其在拉丁美洲市场版图的进一步布局。诺和诺德表示并不担心专利到期，并称这是行业常态。由特朗普发起的全球贸易战不会影响该工厂，因为美国并非巴西制造产品的目的地，而且诺和诺德正在单独扩大其在美国的生产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410042354a4541734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410042354a4541734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","BK4585","BK4588","BK4007","BK4532","NVO"],"gpt_icon":1},{"id":"2526994333","title":"諾和諾德盤中異動 早盤股價大跌3.00%報59.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526994333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526994333?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 22:51","pubTimestamp":1744210265,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日22时51分，诺和诺德股票出现波动，股价大幅下跌3.00%。截至发稿，该股报59.76美元/股，成交量269.31万股，换手率0.06%，振幅1.56%。诺和诺德股票所在的制药行业中，整体跌幅为3.72%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。健友股份在公告中表示，新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。据FDA官网，它是FDA批准的首个每日一次GLP-1 注射剂仿制药，用于糖尿病治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409225105a6b5914f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409225105a6b5914f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","IE00BKVL7J92.USD","BK4532","LU1093756168.USD","LU1093756325.SGD","BK4007","LU0154236417.USD","BK4585","BK4599","BK4588","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2526393361","title":"美股三大指數開盤漲跌不一","url":"https://stock-news.laohu8.com/highlight/detail?id=2526393361","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526393361?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 22:04","pubTimestamp":1744207440,"startTime":"0","endTime":"0","summary":"4月9日晚，美股三大指数开盘涨跌不一，道指跌0.88%，纳指涨0.18%，标普500指数跌0.43%。默沙东、礼来、辉瑞均跌超3%。消息面，中国对美国所有进口商品再加征50%关税；欧盟投票通过对美征收25%关税反制措施。来源：澎湃财讯\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-04-09/doc-inesqrfq3908448.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-09/doc-inesqrfq3908448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["OEX","LU0306806265.USD",".SPX","LU1023059063.AUD","LU0985481810.HKD","LU0289739699.SGD","LU1883839398.USD","SG9999003800.SGD","LU1057294990.SGD","BK4533","IE00BBT3K403.USD","ESmain","IE00B19Z3581.USD","SG9999002232.USD","BK4599","BK4568","SG9999002224.SGD","LU0456855351.SGD","LU0225771236.USD","LU0058720904.USD","SDS","LU0170899867.USD","IE00BLSP4452.SGD","SH","BK4550","BK4534","SSO","LU0234572021.USD","LU0306807586.USD","IVV","LU0868494617.USD","SPY","BK4504","BK4559","IE00BLSP4239.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4588","LU0321505868.SGD","IE0002270589.USD","LU1894683348.USD","SG9999011175.SGD","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999001176.USD","OEF","LU0225284248.USD"],"gpt_icon":0},{"id":"2526270360","title":"Viking Therapeutics, Inc.盤中異動 早盤快速下挫5.11%報18.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526270360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526270360?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:48","pubTimestamp":1744206502,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时48分，Viking Therapeutics, Inc.股票出现波动，股价大幅跳水5.11%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.10%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。公司临床方案管线包括VK2809、VK5211、VK0214产品。消息层面，截至21时48分，《减肥药市场“太卷”，高盛给予Viking Therapeutics“中性”评级》资讯为影响Viking Therapeutics, Inc.的重要信息。该信息摘要如下：周二，高盛开始对Viking Therapeutics进行跟踪覆盖，给出“中性”评级，将目标价设定为每股30美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921482394d0e04b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921482394d0e04b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4007","VKTX","BK4139","LENZ","BK4599"],"gpt_icon":0},{"id":"2526398231","title":"碩迪生物盤中異動 股價大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526398231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526398231?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:34","pubTimestamp":1744205697,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时34分，硕迪生物股票出现异动，股价快速下挫5.27%。截至发稿，该股报13.41美元/股，成交量2.8786万股，换手率0.05%，振幅1.34%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为1.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921345797334dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025040921345797334dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4007","BK4599"],"gpt_icon":0},{"id":"2526677043","title":"安進盤中異動 急速下挫3.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526677043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526677043?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:32","pubTimestamp":1744205573,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时32分，安进股票出现异动，股价急速下跌3.20%。截至发稿，该股报271.29美元/股，成交量12.2911万股，换手率0.02%，振幅1.78%。机构评级方面，在所有32家参与评级的机构中，47%的券商给予买入建议，44%的券商给予持有建议，9%的券商给予卖出建议。安进股票所在的制药行业中，整体跌幅为2.18%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213253a6b583fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213253a6b583fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","BK4534","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","IE0002141913.USD","AMGN","IE00B2B36J28.USD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0868494617.USD","SG9999001440.SGD","BK4588","BK4566","BK4139","LU0058720904.USD","LU0320765992.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","BK4599","LU0109394709.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","LU2242652126.USD","LU1023059063.AUD","LU0122379950.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2526597362","title":"輝瑞盤中異動 早盤大幅跳水4.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526597362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526597362?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:31","pubTimestamp":1744205485,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时31分，辉瑞股票出现异动，股价急速下挫4.01%。截至发稿，该股报20.97美元/股，成交量449.172万股，换手率0.08%，振幅0.94%。辉瑞股票所在的制药行业中，整体跌幅为2.24%。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。消息层面，截至21时31分，《高盛：下调Pfizer评级，由买入调整至中性评级, 目标价由32.00美元调整至25.00美元。》资讯为影响辉瑞的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213125a453d4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213125a453d4a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","IE000M9KFDE8.USD","LU1894683264.USD","IE00B19Z3B42.SGD","BK4599","BK4592","BK4581","LU1023059063.AUD","LU1894683348.USD","SG9999013999.USD","LU0058720904.USD","BK4007","LU0170899867.USD","LU1883839398.USD","SG9999002224.SGD","BK4585","IE00BBT3K403.USD","LU0868494617.USD","LU0122379950.USD","BK4588","LU0234572021.USD","IE00BLSP4239.USD","LU0321505439.SGD","SG9999001176.SGD","SG9999011175.SGD","IE0002270589.USD","BK4534","BK4533","LU0456855351.SGD","BK4568","LU0321505868.SGD","SG9999002232.USD","IE00B19Z3581.USD","LU0985481810.HKD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999001176.USD","LU0306806265.USD","LU0225771236.USD","LU1066053197.SGD","LU1057294990.SGD","PFE","BK4550","LU0306807586.USD","LU1066051498.USD","LU0225284248.USD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2526362409","title":"禮來盤中異動 股價大跌3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526362409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526362409?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 21:30","pubTimestamp":1744205452,"startTime":"0","endTime":"0","summary":"北京时间2025年04月09日21时30分，礼来股票出现异动，股价快速下跌3.17%。截至发稿，该股报703.22美元/股，成交量7.88万股，换手率0.01%，振幅0.51%。机构评级方面，在所有29家参与评级的机构中，86%的券商给予买入建议，14%的券商给予持有建议，无券商给予卖出建议。礼来股票所在的制药行业中，整体涨幅为0.00%。消息层面，截至21时30分，《高盛：上调Eli Lilly评级，由中性调整至买入评级, 目标价由892.00美元调整至888.00美元。》资讯为影响礼来的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213052aa2c6469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409213052aa2c6469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0471298694.HKD","LU0106261372.USD","LU2324357040.USD","LU1974910355.USD","IE0002141913.USD","LU2491050154.USD","BK4599","LU2237443549.SGD","LU2552382215.SGD","SGXZ51526630.SGD","LU0943347566.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","LU2360106947.USD","LU0320765059.SGD","LU0820561909.HKD","BK4534","LU0006306889.USD","LU1917777945.USD","SG9999015952.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU1232071149.USD","BK4516","LU1814569148.SGD","LU2063271972.USD","BK4533","LU0289739699.SGD","SG9999014880.SGD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU0708995401.HKD","SG9999015986.USD","LU1291159041.SGD","SG9999014914.USD","IE0009355771.USD","IE00BK4W5M84.HKD","LU2361045086.USD","LU1551013425.SGD","LU1983299246.USD","LU0256863902.USD","LU2491049909.HKD","LU1023059063.AUD","LU1988902786.USD","SG9999014906.USD","LU2361044949.HKD","LLY","LU0385154629.USD"],"gpt_icon":1},{"id":"2526344463","title":"環球財經巴西宣佈史上最大醫藥領域私人投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2526344463","media":"新华财经","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526344463?lang=zh_tw&edition=fundamental","pubTime":"2025-04-09 16:25","pubTimestamp":1744187100,"startTime":"0","endTime":"0","summary":"新华财经圣保罗4月9日电 巴西总统卢拉当地时间7日宣布，丹麦制药公司诺和诺德将投资64亿雷亚尔扩建其位于蒙特斯克拉鲁斯市的工厂，这是巴西历史上私营制药公司最大单笔投资。卢拉在参观诺和诺德位于巴西东南部米纳斯吉拉斯州蒙特斯克拉鲁斯的工厂时表示，巴西拥有稳定的政治、法律和经济社会环境以吸引国际投资。卢拉强调了当地市场的可预测性和统一医疗系统的作用，该系统被认为是巴西最大的药品购买者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409162720a4537d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250409162720a4537d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","BK4588","BK4599","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":112,"code":"91000000","status":"200"}]}}